Diagnostic tool enables rapid leukemia subtype classification

September 22, 2025 Medical Xpress.com

Researchers at Dana-Farber Cancer Institute have developed a diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided Rapid Leukemia Subtype Inference), uses DNA methylation patterns and machine learning to classify acute leukemia with speed and accuracy. This tool has the potential to significantly improve patient care by allowing faster and more precise treatment decisions.

This article was originally published on MedicalXpress.com

Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works

May 28, 2023 Community Partners

Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]

Exploring Attachment Styles and How They Affect Adult Relationships

April 3, 2023 Community Partners

Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]

The Key to a Strong Relationship? Communication

August 2, 2023 Community Partners

Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]

New intervention helps pediatricians promote early peanut introduction to prevent allergy

October 6, 2025 Medical Xpress.com

Results from a randomized clinical trial published in Pediatrics show that pediatricians who received targeted educational and clinical decision-support tools were significantly more likely to [...]
FDA approves Tremfya for pediatric plaque psoriasis, active psoriatic arthritis

October 3, 2025 Medical Xpress.com

The U.S. Food and Drug Administration has approved Johnson & Johnson’s Tremfya (guselkumab) for the treatment of plaque psoriasis and active psoriatic arthritis in children [...]
Affluence protects children from obesity, even in areas with lots of unhealthy food outlets

October 2, 2025 Medical Xpress.com

Family affluence shields children from the risks of obesity and unhealthy eating habits, even when they’re surrounded by unhealthy food options, according to a study [...]

Diagnostic tool enables rapid leukemia subtype classification

You may also be interested in:

Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works

Exploring Attachment Styles and How They Affect Adult Relationships

The Key to a Strong Relationship? Communication

Read More:

New intervention helps pediatricians promote early peanut introduction to prevent allergy

FDA approves Tremfya for pediatric plaque psoriasis, active psoriatic arthritis

Affluence protects children from obesity, even in areas with lots of unhealthy food outlets